IOL Chemicals [IOLCP] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: IOL Chemicals and Pharmaceuticals Ltd. wins in 9 metrics, Innova Captab Ltd. wins in 11 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric IOL Chemicals and Pharmaceuticals Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 23.83 31.20 IOL Chemicals and Pharmaceuticals Ltd.
Price-to-Book Ratio 1.58 4.05 IOL Chemicals and Pharmaceuticals Ltd.
Debt-to-Equity Ratio 9.08 32.95 IOL Chemicals and Pharmaceuticals Ltd.
PEG Ratio 18.10 1.33 Innova Captab Ltd.
EV/EBITDA 11.58 20.49 IOL Chemicals and Pharmaceuticals Ltd.
Profit Margin (TTM) 5.20% 8.85% Innova Captab Ltd.
Operating Margin (TTM) 6.39% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) 6.39% 12.88% Innova Captab Ltd.
Return on Equity 5.99% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 4.24% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $-349.30M $-1.09B IOL Chemicals and Pharmaceuticals Ltd.
Dividend Yield 1.56% 0.30% IOL Chemicals and Pharmaceuticals Ltd.
1-Year Return 51.26% 3.87% IOL Chemicals and Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 1.24 2.76 IOL Chemicals and Pharmaceuticals Ltd.
Enterprise Value $27.55B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 1.24 2.90 IOL Chemicals and Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 34.11% 35.19% Innova Captab Ltd.
Revenue per Share (TTM) $76 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $3.95 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.03 -0.33 Innova Captab Ltd.

IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
IOL Chemicals and Pharmaceuticals Ltd.-0.54%5.20%26.03%94.47%61.90%62.47%
Innova Captab Ltd.0.58%8.95%10.45%34.08%34.58%28.37%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
IOL Chemicals and Pharmaceuticals Ltd.51.26%50.19%8.16%401.08%1,759.28%1,189.53%
Innova Captab Ltd.3.87%74.08%74.08%74.08%74.08%74.08%

Performance & Financial Health Analysis: IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricIOLCPINNOVACAP
Market Information
Market Cap i₹27.17B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,912,191578,151
90 Day Avg. Volume i1,858,936217,693
Last Close₹133.52₹947.95
52 Week Range₹67.19 - ₹139.99₹622.00 - ₹978.00
% from 52W High-4.62%-3.07%
All-Time High₹179.78 (Aug 24, 2020)₹1,260.00 (Jan 06, 2025)
% from All-Time High-25.73%-24.77%
Growth Metrics
Quarterly Revenue Growth0.11%0.42%
Quarterly Earnings Growth0.00%0.23%
Financial Health
Profit Margin (TTM) i0.05%0.09%
Operating Margin (TTM) i0.06%0.13%
Return on Equity (TTM) i0.06%0.13%
Debt to Equity (MRQ) i9.0832.95
Cash & Liquidity
Book Value per Share (MRQ)₹59.60₹178.28
Cash per Share (MRQ)₹5.84₹10.22
Operating Cash Flow (TTM) i₹1.67B₹282.88M
Levered Free Cash Flow (TTM) i₹1.01B₹1.28B
Dividends
Last 12-Month Dividend Yield i1.56%0.30%
Last 12-Month Dividend i₹1.16₹2.00

Valuation & Enterprise Metrics Analysis: IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricIOLCP (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i23.8331.20
Forward P/E i18.1021.90
PEG Ratio i18.101.33
Price to Sales (TTM) i1.242.76
Price to Book (MRQ) i1.584.05
Market Capitalization
Market Capitalization i₹27.17B₹41.43B
Enterprise Value i₹27.55B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i1.242.90
Enterprise to EBITDA i11.5820.49
Risk & Other Metrics
Beta i0.03-0.33
Book Value per Share (MRQ) i₹59.60₹178.28

Financial Statements Comparison: IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIOLCP (2025)INNOVACAP (2025)
Revenue/Sales i20.68B12.34B
Cost of Goods Sold i14.14B8.38B
COGS % of Revenue i68.4%67.9%
Gross Profit i6.54B3.96B
Gross Margin i31.6%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i1.31B1.65B
Operating Margin i6.3%13.4%
EBITDA i2.19B2.00B
EBITDA Margin i10.6%16.2%
Pre-Tax Income i1.38B1.71B
Pre-Tax Income % of Revenue i6.7%13.9%
Income Tax i368.90M427.58M
Income Tax % of Revenue i1.8%3.5%
Net Income (Profit) i1.01B1.28B
Profit Margin i4.9%10.4%

Balance Sheet & Liquidity Metrics

MetricIOLCP (2025)INNOVACAP (2025)
Cash & Equivalents i781.70M155.19M
Total Current Assets i11.51B7.03B
Total Current Assets % of Revenue i55.7%57.0%
Total Current Liabilities i6.10B3.53B
Total Current Liabilities % of Revenue i29.5%28.6%
Long-Term Debt i02.45B
Long-Term Debt % of Revenue i0.0%19.8%
Total Shareholders Equity i16.88B9.59B
Retained Earnings i14.02B4.53B
Retained Earnings % of Revenue i67.8%36.7%
Property, Plant & Equipment i5.30M442.93M

Cash Flow Statement Comparison

MetricIOLCP (2025)INNOVACAP (2025)
Operating Cash Flow i1.67B282.88M
Operating Cash Flow % of Revenue i8.1%2.3%
Capital Expenditures i-2.13B-1.72B
Free Cash Flow i-349.30M-1.09B
FCF Margin i-1.7%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricIOLCPINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i293.53M57.22M
Float Shares i83.67M15.91M
% Held by Insiders i63.11%72.19%
% Held by Institutions i1.29%19.22%
% Held by Public i35.60%8.59%

Dividend Analysis & Yield Comparison: IOL Chemicals and Pharmaceuticals Ltd. vs Innova Captab Ltd.

MetricIOLCPINNOVACAP
Last 12-Month Dividend i₹1.16₹2.00
Last 12-Month Dividend Yield i1.56%0.30%
3-Year Avg Annual Dividend i₹0.45₹0.67
3-Year Avg Dividend Yield i0.60%0.30%
3-Year Total Dividends i₹1.36₹2.00
Ex-Dividend DateFeb 17, 2026Jan 30, 2026